On April, 11th, Shanghai Bio-lu Biomaterials organized the first convention on innovative mini-invasive techniques to treat Avascular Necrosis of the Femoral Head (ANFH) in Shanghai Everbright Convention and Exhibition Center. With special guest-speakers Pr. Wang Zhen from Xian Xijing Hospital and Pr. Sun Wei from Beijing China-Japan Friendship Hospital, and over one hundred orthopedic surgeons from Chinese and French hospitals, Pr. Lu Jianxi presented his new BioRod mini-invasive technique, as an innovative alternative to traditional methods such as joint replacement.
The surgeons presented their own clinical cases and shared their experience of the BioRod. This product has been shown to be effective in treating a wide range of ANFH, ranging from early stage II to collapsed stage III cases. With over 250 operations, the success rate of the BioRod is over 95%, imposing itself as an effective implant to restore the quality of life of the patients.